Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of chronic diseases
3.2.1.2 Rising Investments and funding in cell-based research
3.2.1.3 Increasing adoption of personalized medicine
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of cell signaling systems
3.2.2.2 Ethical and safety concerns
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Consumables
5.2.1 Antibodies
5.2.2 Reagents
5.2.3 Assay kits
5.2.4 Other consumables
5.3 Instruments
Chapter 6 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Endocrine signaling
6.3 Paracrine signaling
6.4 Autocrine signaling
6.5 Juxtacrine signaling
6.6 Other types
Chapter 7 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Flow cytometry
7.3 Microscopy
7.4 Western blotting
7.5 ELISA
7.6 Other technologies
Chapter 8 Market Estimates and Forecast, By Signaling Pathway, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 AKT signaling pathway
8.3 AMPK signaling pathway
8.4 ErbB/HER signaling pathway
8.5 Hedgehog signaling pathway
8.6 JAK-STAT signaling pathway
8.7 NF-kB signaling pathway
8.8 Notch signaling pathway
8.9 Other signaling pathways
Chapter 9 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Research applications
9.3 Medical applications
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Becton, Dickinson and Company
11.2 Bio-Rad Laboratories Inc.
11.3 Bio-Techne Corporation
11.4 Cell Signaling Technology Inc.
11.5 Danaher Corporation
11.6 Merck KGaA
11.7 PerkinElmer Inc.
11.8 Promega Corporation
11.9 QIAGEN N.V.
11.10 Thermo Fisher Scientific, Inc.
